MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

08-Jun-2017 - MRC Technology and Biocartis Group NV announced a partnership to develop selected molecular diagnostic tests for use on Biocartis' fully automated Idylla(TM) platform. MRCT aims to move promising medical research forward into patient treatments and diagnostics and has been involved in helping ...

Biocartis announces its new CEO

10-May-2017 - Biocartis Group announces Herman Verrelst as its new Chief Executive Officer (CEO), effective as of August 2017. Herman is a seasoned executive and serial entrepreneur with a proven international commercial track-record in molecular diagnostics. Herman currently holds the position of Vice ...

Merck and Biocartis to Collaborate

08-Jan-2016 - Merck announced that it has signed a collaboration agreement with Biocartis for the development and commercialization of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC). The test will be developed on Biocartis’ innovative, fully automated molecular ...

Biocartis and Fast-track diagnostics sign strategic collaboration in infectious diseases

28-May-2015 - Biocartis and Fast-track diagnostics announced that they have entered into a strategic collaboration to develop a range of multiplex infectious disease tests to run on the Biocartis Idylla™ system.Biocartis and Fast-track diagnostics plan to collaborate on a new approach to infectious disease ...

Biocartis collaborates with Philips and Wellcome Trust in oncology diagnostics

Collaboration to develop an automated blood based assay-system for monitoring tumor load

30-May-2012 - Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full IP ...

Biocartis named as a technology pioneer 2012 by the World Economic Forum

05-Sep-2011 - Biocartis announced that it has been selected as a Technology Pioneer 2012 by the World Economic Forum. Technology Pioneers comprise 25 of the most innovative young companies from around the world, companies poised to have a critical impact on how business and society work.The Technology Pioneers ...

bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics

Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012

09-Nov-2010 - bioMérieux and Biocartis announced that they have entered into a strategic agreement to co-develop assays on Biocartis’ fully integrated molecular diagnostics system, which the two companies will co-distribute starting in 2012. Under the agreement, bioMérieux will have worldwide exclusive rights ...